Realbotix Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '13 Sep 30, 2013
Net Income	-	-6.37	-12.62	-4.33	-3.18
Depreciation & Amortization	0.54	0.66	0.4	-	0.12
Stock-Based Compensation	0.38	0.41	0.29	0.15	0.14
Other Adjustments	-0.38	1.02	9.13	2.46	-0.41
Change in Receivables	-	-	-	-	-0.02
Changes in Accounts Payable	-	-	-	-	0.26
Changes in Other Operating Activities	-	-	-0.59	-1.51	0.02
Operating Cash Flow	-6.3	-10.84	-7.54	-1.71	-3.05
Capital Expenditures	-	-	-	-	-0.01
Purchases of Intangible Assets	-	-	-	-0.2	-
Purchases of Investments	-	-	0.24	-	-
Proceeds from Sale of Investments	2.49	-	-	1.36	-
Other Investing Activities	-1.5	-0.49	-0.18	-0.35	1.23
Investing Cash Flow	2.27	-0.49	0.24	1.16	1.22
Issuance of Common Stock	2.87	0.46	0.13	0.03	-
Net Common Stock Issued (Repurchased)	2.87	0.46	0.13	0.03	-
Other Financing Activities	2.02	-0.08	-0.1	-	-
Financing Cash Flow	6.4	-0.98	-0.57	-0.32	-
Net Cash Flow	2.18	7.5	-4.1	-2.35	-1.83
Free Cash Flow	-6.3	-10.84	-7.54	-1.71	-3.05
FCF Margin	-417.80%	-538.34%	-826.77%	-639.12%	-
Free Cash Flow Per Share	-	-	-0.05	-0.02	-0.88
Levered Free Cash Flow	-2.14	-4.25	-8.86	-11.65	3.57
Unlevered Free Cash Flow	-5.91	-5.55	-3.7	-2.81	0.4

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.